logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment

Pedrique B, Strub-Wourgaft N, Some C, Olliaro PL, Trouiller P,  et al.
2013-12-01 • Lancet Global Health
2013-12-01 • Lancet Global Health
In 1975-99, only 1·1% of new therapeutic products had been developed for neglected diseases. Since then, several public and private initiatives have attempted to mitigate this imbalance....
Journal Article
|
Research

Access to Essential Drugs in Poor Countries: A Lost Battle?

Pécoul B, Chirac P, Trouiller P, Pinel J
1999-01-27 • JAMA
1999-01-27 • JAMA
Drugs offer a simple, cost-effective solution to many health problems, provided they are available, affordable, and properly used. However, effective treatment is lacking in poor countri...
Journal Article
|
Research

Drug development for neglected diseases: a deficient market and a public-health policy failure

Trouiller P, Olliaro PL, Torreele E, Orbinski J, Laing R,  et al.
2002-06-22 • Lancet
2002-06-22 • Lancet
There is a lack of effective, safe, and affordable pharmaceuticals to control infectious diseases that cause high mortality and morbidity among poor people in the developing world. We an...